Karen Firestone
Director, Amylyx Pharmaceuticals.
Companies
- Amylyx PharmaceuticalsBoard member Mar 20, 2023 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Amylyx Pharmaceuticals AMLX116,900 shares2$3.2M at $27.07Aug 31, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 31, 2026Exercised options 25,000 shares at $5.05 of Amylyx Pharmaceuticals2
- Aug 31, 2026Exercised options 25,000 shares at $1.76 of Amylyx Pharmaceuticals2
- May 21, 2026Bought 3,800 shares at $13.51 of Amylyx Pharmaceuticals3
- Dec 23, 2025Bought 8,100 shares at $12.45 of Amylyx Pharmaceuticals4
- Sep 5, 2024Bought 50,000 shares at $2.13 of Amylyx Pharmaceuticals5
- Dec 15, 2023Bought 4,000 shares at $14.97 of Amylyx Pharmaceuticals6
- Mar 16, 2023Bought 1,000 shares at $31.99 of Amylyx Pharmaceuticals7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAmylyx Pharmaceuticals, Board member
- 2
- 3SEC EDGARForm 4 filed May 26, 2026
- 4SEC EDGARForm 4 filed Dec 23, 2025
- 5SEC EDGARForm 4 filed Sep 9, 2024
- 6SEC EDGARForm 4 filed Dec 19, 2023
- 7SEC EDGARForm 4 filed Mar 20, 2023